Daclatasvir Nitroso
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Daclatasvir is used along with another medication (sofosbuvir [Solvadi]) to treat a certain type of chronic hepatitis C (an ongoing viral infection that damages the liver). Daclatasvir is in a class of antiviral medications called hepatitis C virus (HCV) NS5A inhibitors.Daclatasvir Nitroso is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Daclatasvir Nitroso CAS NO:NA chemically represented as Methyl ((S)-1-((S)-2-(5-(4'-(2-((S)-1-((methoxycarbonyl)-L-valyl)pyrrolidin-2-yl)-1H-imidazol-5-yl)-[1,1'-biphenyl]-4-yl)-1-nitroso-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate. Synchemia is the leading manufacturing and exporter of Daclatasvir Nitroso . We supply Daclatasvir Nitroso with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N014663 |
| CAS No | NA |
| Mol.F. | C23H29N9O2 |
| Mol.Wt. | 463.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014664 |
| CAS No | NA |
| Mol.F. | C24H15N7O |
| Mol.Wt. | 417.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014665 |
| CAS No | NA |
| Mol.F. | C24H14N8O2 |
| Mol.Wt. | 446.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014666 |
| CAS No | NA |
| Mol.F. | C19H17FN4O2 |
| Mol.Wt. | 352.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014667 |
| CAS No | NA |
| Mol.F. | C19H16FN5O3 |
| Mol.Wt. | 381.37 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014668 |
| CAS No | NA |
| Mol.F. | C19H17FN4O2 |
| Mol.Wt. | 352.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014669 |
| CAS No | NA |
| Mol.F. | C17H17N7O |
| Mol.Wt. | 335.4 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N014670 |
| CAS No | 3036581-81-1 |
| Mol.F. | C25H36N2O5 |
| Mol.Wt. | 444.6 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N014671 |
| CAS No | NA |
| Mol.F. | C6H9N5O2 |
| Mol.Wt. | 183.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014672 |
| CAS No | NA |
| Mol.F. | C4H5N5O4S2 |
| Mol.Wt. | 251.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014673 |
| CAS No | NA |
| Mol.F. | C5H3N5OS |
| Mol.Wt. | 181.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014674 |
| CAS No | NA |
| Mol.F. | C5H7N3O3 |
| Mol.Wt. | 157.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014675 |
| CAS No | NA |
| Mol.F. | C19H24N4O |
| Mol.Wt. | 324.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014676 |
| CAS No | 2208229-54-1 |
| Mol.F. | C8H10N2O |
| Mol.Wt. | 150.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014677 |
| CAS No | NA |
| Mol.F. | C17H18N2O2 |
| Mol.Wt. | 282.34 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014678 |
| CAS No | NA |
| Mol.F. | C8H14N8O3S3 |
| Mol.Wt. | 366.4 |
| INV STATUS | CUSTOM SYNTHESIS |